{"disease":{"id":"hpv","name":"hpv"},"drugs":{"marketed":[{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Human papillomavirus (HPV)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Human papillomavirus (HPV) booster","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Human papillomavirus (HPV) booster (immunocompromised)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Human papillomavirus (HPV) booster (pregnancy)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Human papillomavirus (HPV) booster (adolescent)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Human papillomavirus (HPV) booster (adult)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Human papillomavirus (HPV) booster (immunocompromised)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Human papillomavirus (HPV) booster (pregnancy)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Human papillomavirus (HPV) booster (adolescent)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":9,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07314307","title":"Vaccine Effectiveness of One Dose of the Nonavalent Human Papillomavirus (HPV) Vaccine Among Young-adult Women in Sweden Among Women Participating in a Clinical Trial of Concomitant HPV Vaccination and Screening","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":150000,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT04910802","title":"Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":150000,"lead_sponsor_name":"Miriam Elfström","has_results":false},{"nct_id":"NCT06631495","title":"All-cause and Diseases-specific Mortality of High-risk HPV Infection","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":100000,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT02456077","title":"Strengthening Physician Communication About HPV Vaccines","phase":"NA","overall_status":"COMPLETED","enrollment_count":93582,"lead_sponsor_name":"University of Colorado, Denver","has_results":false},{"nct_id":"NCT02993965","title":"State Immunization Information Systems to Improve HPV Vaccination Rates","phase":"NA","overall_status":"COMPLETED","enrollment_count":77716,"lead_sponsor_name":"University of Colorado, Denver","has_results":false},{"nct_id":"NCT05536674","title":"SMS Reminders to Strengthen Demand for HPV Vaccination in Georgia","phase":"NA","overall_status":"UNKNOWN","enrollment_count":55176,"lead_sponsor_name":"The Behavioural Insights Team","has_results":false},{"nct_id":"NCT05996783","title":"Cervical Cancer Screening Based on First-void Urine Self-sampling to Reach un(Der)-Screened Women: ScreenUrSelf Trial","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":48000,"lead_sponsor_name":"Universiteit Antwerpen","has_results":false},{"nct_id":"NCT04679675","title":"Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":32771,"lead_sponsor_name":"Kaiser Permanente","has_results":true},{"nct_id":"NCT04945655","title":"Impact of a School- and Primary Care-based Multicomponent Intervention on HPV Vaccination Acceptability","phase":"NA","overall_status":"COMPLETED","enrollment_count":30739,"lead_sponsor_name":"Institut National de la Santé Et de la Recherche Médicale, France","has_results":false},{"nct_id":"NCT05234112","title":"Prevention and Screening Towards Elimination of Cervical Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":30000,"lead_sponsor_name":"University Medical Center Groningen","has_results":false},{"nct_id":"NCT05006833","title":"Text and Talk: A Multi-level Intervention to Increase Provider HPV Vaccine Recommendation Effectiveness","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":21110,"lead_sponsor_name":"University of Florida","has_results":false},{"nct_id":"NCT07351604","title":"Effectiveness of Large Language Model-Based Chatbot Among Female University Stdents in Improving HPV Vaccine Awareness, Intention and Vaccination Rates","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":18000,"lead_sponsor_name":"Xiamen University","has_results":false},{"nct_id":"NCT07525245","title":"Effectiveness of Large Language Model-Based Chatbot Among Parents of Junior High School Girls in Improving Human Papillomavirus (HPV) Vaccine Awareness, Intention and Vaccination Rates","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":18000,"lead_sponsor_name":"Xiamen University","has_results":false},{"nct_id":"NCT07200414","title":"Strengthening HPV Vaccination and Adolescent Health Research Program in Nigeria (SHARP)","phase":"NA","overall_status":"COMPLETED","enrollment_count":12654,"lead_sponsor_name":"Johns Hopkins Bloomberg School of Public Health","has_results":false},{"nct_id":"NCT07358910","title":"Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Institut Pasteur du Cambodge","has_results":false},{"nct_id":"NCT06619743","title":"HPV Infection and Vaginal Microecology in Immunosuppressed Women","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Lan Zhu","has_results":false},{"nct_id":"NCT06815939","title":"Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"DL Analytics","has_results":false},{"nct_id":"NCT06105346","title":"Prevalence of ENT Diseseas","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Medical University of Graz","has_results":false},{"nct_id":"NCT06465914","title":"A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":9000,"lead_sponsor_name":"Shanghai Bovax Biotechnology Co., Ltd.","has_results":false},{"nct_id":"NCT05173324","title":"Integration of HPV Vaccination and HPV-based Cervical Screening Into ARV Clinics: the H2VICTORY Trial","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":8000,"lead_sponsor_name":"International Agency for Research on Cancer","has_results":false},{"nct_id":"NCT01231945","title":"Low-Cost Molecular Cervical Cancer Screening Study","phase":"","overall_status":"COMPLETED","enrollment_count":7500,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT06843720","title":"Expanding Access to Cervical Cancer Screening Through Primary HR-HPV Testing and Self-sampling: a Multicomponent Intervention for Safety Net Health Systems","phase":"NA","overall_status":"RECRUITING","enrollment_count":7100,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT05848557","title":"mSaada: A Mobile Health Tool","phase":"NA","overall_status":"RECRUITING","enrollment_count":6000,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT04859530","title":"Automated Cervical Cancer Screening Using a Smartphone-based Artificial Intelligence Classifier","phase":"NA","overall_status":"RECRUITING","enrollment_count":5886,"lead_sponsor_name":"Prof. Patrick Petignat","has_results":false},{"nct_id":"NCT01086709","title":"Crossover Vaccination of Women Previously Randomized Into Protocol 04-C-N191","phase":"","overall_status":"COMPLETED","enrollment_count":5444,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04766164","title":"Health Beliefs, Behaviors, and Healthcare Experiences Among United States Young and Mid-Age Adults","phase":"","overall_status":"COMPLETED","enrollment_count":4000,"lead_sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","has_results":false},{"nct_id":"NCT05282745","title":"A Multicenter Cohort Study of HPV Viral Load in Predicting the Postoperative Recurrence of HSIL","phase":"","overall_status":"UNKNOWN","enrollment_count":4000,"lead_sponsor_name":"Fujian Maternity and Child Health Hospital","has_results":false},{"nct_id":"NCT01062074","title":"GARDASIL Reexamination Study (V501-059)","phase":"","overall_status":"COMPLETED","enrollment_count":3605,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT07498075","title":"A Randomized Trial of Digital Interventions to Increase HPV Vaccination Intentions Among Nigerian Caregivers","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":3340,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT05247853","title":"HPV Vaccine Effectiveness Study in Rwandan Women Living With HIV","phase":"","overall_status":"COMPLETED","enrollment_count":3127,"lead_sponsor_name":"Montefiore Medical Center","has_results":false},{"nct_id":"NCT04722822","title":"The HPV 9-10 Trial: Early Initiation of HPV Vaccination","phase":"NA","overall_status":"RECRUITING","enrollment_count":3100,"lead_sponsor_name":"University of Colorado, Denver","has_results":false},{"nct_id":"NCT00943722","title":"A Study of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolescents and Adolescents (V503-002)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3074,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT00834106","title":"Prevention of Human Papillomavirus (HPV) in 20 to 45 Year Old Chinese Women (V501-041)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3006,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT03105856","title":"FASTER-Tlalpan Study in Mexico: HPV Vaccination Impact on Cervical Cancer Screening Program","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":3000,"lead_sponsor_name":"Instituto Nacional de Salud Publica, Mexico","has_results":false},{"nct_id":"NCT06921798","title":"Remote Resilience: Novel Applications of mHealth in Nicaragua's Cancer Control Program","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":3000,"lead_sponsor_name":"University of Virginia","has_results":false},{"nct_id":"NCT06137352","title":"Two Domestic HPV Vaccines and Imported HPV Vaccines in Women Aged 13-14 Years Study on Immunogenicity","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Fujian Maternity and Child Health Hospital","has_results":false},{"nct_id":"NCT06831929","title":"HPV Ends Here: Increasing Uptake of the HPV Vaccine","phase":"NA","overall_status":"RECRUITING","enrollment_count":2232,"lead_sponsor_name":"University of California, Davis","has_results":false},{"nct_id":"NCT05570331","title":"Clinical Evaluation of HPV Integration Triage for Detection of Cervical Precancer in HPV-positive Women","phase":"","overall_status":"UNKNOWN","enrollment_count":2200,"lead_sponsor_name":"Ding Ma","has_results":false},{"nct_id":"NCT04757701","title":"The Role of Dentists in Human Papillomavirus Vaccination","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"East Carolina University","has_results":false},{"nct_id":"NCT06728085","title":"A Pragmatic Trial on Actions For Collaborative Community Engaged Strategies for HPV","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1838,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT06227689","title":"Effectiveness of Vaccine Chatbot on HPV Vaccine Awareness and Vaccination in China","phase":"NA","overall_status":"RECRUITING","enrollment_count":1800,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT05050162","title":"Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer","phase":"PHASE2, PHASE3","overall_status":"SUSPENDED","enrollment_count":1714,"lead_sponsor_name":"NRG Oncology","has_results":false},{"nct_id":"NCT04794660","title":"The Study for the \"Cervical Cancer Screening and Treatment Algorithms Study Using HPV Testing in Africa\"","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":1500,"lead_sponsor_name":"International Agency for Research on Cancer","has_results":false},{"nct_id":"NCT07217145","title":"PREVENT HPV -Related Cancers Trial","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1455,"lead_sponsor_name":"University of Utah","has_results":false},{"nct_id":"NCT04982614","title":"HPV Vaccination in HIV Infected and HIV Uninfected Adolescents in Eswatini","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":1403,"lead_sponsor_name":"Columbia University","has_results":false},{"nct_id":"NCT05027776","title":"Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":1348,"lead_sponsor_name":"Shanghai Bovax Biotechnology Co., Ltd.","has_results":false},{"nct_id":"NCT04438291","title":"HPV Vaccination Health-promotion Programme on Vaccine Acceptance and Uptake Among Female Adolescents","phase":"NA","overall_status":"COMPLETED","enrollment_count":1340,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT03429413","title":"Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":1296,"lead_sponsor_name":"University of Florida","has_results":false},{"nct_id":"NCT07256912","title":"A Trial to Establish Non-inferiority of Immunogenicity of a Single-dose of CERVAVAC® Quadrivalent HPV Vaccine Compared to the Gardasil® Quadrivalent Vaccine Among Girls and Boys Aged 9 to 14 Years and in Girls/Women Aged 15 to 20 Years in Zambia","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":1266,"lead_sponsor_name":"International Agency for Research on Cancer","has_results":false},{"nct_id":"NCT04092257","title":"HPV-Based Screen-and-Treat Demonstration Project in Lilongwe","phase":"NA","overall_status":"COMPLETED","enrollment_count":1250,"lead_sponsor_name":"UNC Lineberger Comprehensive Cancer Center","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}